Cesca Therapeutics (KOOL) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts KOOL Hot Sheet
Price: $14.96 +0.47%
Financial Fact:
Total operating expenses: 3.33M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Total operating expenses: 3.33M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cesca Therapeutics (NASDAQ: KOOL) reported Q1 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $3.71 million.
For earnings history and earnings-related data on Cesca Therapeutics (KOOL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- SuperCom (SPCB) Tops Q3 EPS by 43c
- Ideal Power (IPWR) Tops Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
